VAERS data in CDC WONDER are updated every Friday. Hence, results for the same query can change from week to week.
|
Event Category |
|
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COVID19 (COVID19 (JANSSEN)) (1203) | Death | 29 | 0.06% | ||||||||||
| Life Threatening | 33 | 0.07% | |||||||||||
| Permanent Disability | 17 | 0.03% | |||||||||||
| Congenital Anomaly / Birth Defect * | 1 | 0.00% | |||||||||||
| Hospitalized | 116 | 0.23% | |||||||||||
| Existing Hospitalization Prolonged | 4 | 0.01% | |||||||||||
| Emergency Room * | 252 | 0.50% | |||||||||||
| Office Visit * | 177 | 0.35% | |||||||||||
| None of the above | 2,320 | 4.57% | |||||||||||
| Total | 2,949 | 5.81% | |||||||||||
| COVID19 (COVID19 (MODERNA)) (1201) | Death | 1,130 | 2.23% | ||||||||||
| Life Threatening | 696 | 1.37% | |||||||||||
| Permanent Disability | 436 | 0.86% | |||||||||||
| Congenital Anomaly / Birth Defect * | 24 | 0.05% | |||||||||||
| Hospitalized | 2,353 | 4.64% | |||||||||||
| Existing Hospitalization Prolonged | 31 | 0.06% | |||||||||||
| Emergency Room / Office Visit ** | 7 | 0.01% | |||||||||||
| Emergency Room * | 3,271 | 6.45% | |||||||||||
| Office Visit * | 3,687 | 7.27% | |||||||||||
| None of the above | 13,419 | 26.46% | |||||||||||
| Total | 25,054 | 49.40% | |||||||||||
| COVID19 (COVID19 (PFIZER-BIONTECH)) (1200) | Death | 1,019 | 2.01% | ||||||||||
| Life Threatening | 767 | 1.51% | |||||||||||
| Permanent Disability | 498 | 0.98% | |||||||||||
| Congenital Anomaly / Birth Defect * | 32 | 0.06% | |||||||||||
| Hospitalized | 2,478 | 4.89% | |||||||||||
| Existing Hospitalization Prolonged | 25 | 0.05% | |||||||||||
| Emergency Room / Office Visit ** | 22 | 0.04% | |||||||||||
| Emergency Room * | 4,861 | 9.58% | |||||||||||
| Office Visit * | 4,058 | 8.00% | |||||||||||
| None of the above | 16,557 | 32.65% | |||||||||||
| Total | 30,317 | 59.78% | |||||||||||
| COVID19 (COVID19 (UNKNOWN)) (1202) | Death | 12 | 0.02% | ||||||||||
| Life Threatening | 2 | 0.00% | |||||||||||
| Permanent Disability | 1 | 0.00% | |||||||||||
| Hospitalized | 13 | 0.03% | |||||||||||
| Emergency Room * | 6 | 0.01% | |||||||||||
| Office Visit * | 5 | 0.01% | |||||||||||
| None of the above | 14 | 0.03% | |||||||||||
| Total | 53 | 0.10% | |||||||||||
| Total | 58,373 | 115.10% | |||||||||||
| Notes: | |
|---|---|
| Caveats: |
VAERS accepts reports of adverse events and reactions that occur following vaccination. Healthcare providers, vaccine manufacturers, and the public can submit reports to VAERS. While very important in monitoring vaccine safety, VAERS reports alone cannot be used to determine if a vaccine caused or contributed to an adverse event or illness. The reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This creates specific limitations on how the data can be used scientifically. Data from VAERS reports should always be interpreted with these limitations in mind. The strengths of VAERS are that it is national in scope and can quickly provide an early warning of a safety problem with a vaccine. As part of CDC and FDA's multi-system approach to post-licensure vaccine safety monitoring, VAERS is designed to rapidly detect unusual or unexpected patterns of adverse events, also known as "safety signals." If a safety signal is found in VAERS, further studies can be done in safety systems such as the CDC's Vaccine Safety Datalink (VSD) or the Clinical Immunization Safety Assessment (CISA) project. These systems do not have the same limitations as VAERS, and can better assess health risks and possible connections between adverse events and a vaccine. Key considerations and limitations of VAERS data:
Some items may have more than 1 occurrence in any single event report, such as Symptoms, Vaccine Products, Manufacturers, and Event Categories. If data are grouped by any of these items, then the number in the Events Reported column may exceed the total number of unique events. If percentages are shown, then the associated percentage of total unique event reports will exceed 100% in such cases. For example, the number of Symptoms mentioned is likely to exceed the number of events reported, because many reports include more than 1 Symptom. When more then 1 Symptom occurs in a single report, then the percentage of Symptoms to unique events is more than 100%. More information. Data contains VAERS reports processed as of 3/26/2021. The VAERS data in WONDER are updated weekly, yet the VAERS system receives continuous updates including revisions and new reports for preceding time periods. More information. Under Title 21, Code of Federal Regulations Section 600.80, a serious event is defined with any of the following outcomes: Death, a life-threatening adverse experience, inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant disability/incapacity, or a congenital anomaly/birth defect. Values of Event Category field vary in their availability over time due to changes in the reporting form. The "Emergency Room/Office Visit" value was avaliable only for events reported using the VAERS-1 form, active 07/01/1990 to 06/29/2017. The "Congenital Anomaly/Birth Defect", "Emergency Room", and "Office Visit" values are available only for events reported using the VAERS 2.0 form, active 06/30/2017 to present. These changes must be considered when evaluating count of events for these categories. For more information on how many persons have been vaccinated in the US for COVID19 to date, see https://covid.cdc.gov/covid-data-tracker/#vaccinations/
|
| Help: | See The Vaccine Adverse Event Reporting System (VAERS) Documentation for more information. |
| Query Date: | Apr 3, 2021 11:00:32 AM |
